Previous studies have reported high-level expression of the somatostatin receptor 2 (SSTR2) subtype in GIST tumours with unknown mutational status [15] and that GIST tumour sites can be identified with 111In-Octreotide scintigraphy in 3/6 cases [16]. Here, SSTR2 is linked to gastrointestinal stromal tumor.